Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9623096rdf:typepubmed:Citationlld:pubmed
pubmed-article:9623096lifeskim:mentionsumls-concept:C0205476lld:lifeskim
pubmed-article:9623096lifeskim:mentionsumls-concept:C0152036lld:lifeskim
pubmed-article:9623096lifeskim:mentionsumls-concept:C0161815lld:lifeskim
pubmed-article:9623096lifeskim:mentionsumls-concept:C2895206lld:lifeskim
pubmed-article:9623096lifeskim:mentionsumls-concept:C0032893lld:lifeskim
pubmed-article:9623096pubmed:issue10lld:pubmed
pubmed-article:9623096pubmed:dateCreated1998-7-2lld:pubmed
pubmed-article:9623096pubmed:abstractTextComplications of the central nervous system (CNS) are common in systemic autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus (SLE) and primary Sjögren's syndrome. Specific diagnostic tests are lacking and early intervention with immunosuppressive therapy is frequently necessary. Therefore knowledge of these CNS complications is essential for early diagnosis and treatment. Residual cognitive effects were observed in some but not in all tests after prolonged heavy cannabis use. The effects were mostly mild. The relationship of cannabis use, psychotic effects and schizophrenia was unclear; the cannabis conceivably gave relief, but it also appeared that cannabis caused schizophrenia in young people and (or) enhanced the symptoms, especially in young people poorly able to cope with stress or in whom the antipsychotic therapy was unsuccessful.lld:pubmed
pubmed-article:9623096pubmed:languagedutlld:pubmed
pubmed-article:9623096pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9623096pubmed:citationSubsetIMlld:pubmed
pubmed-article:9623096pubmed:statusMEDLINElld:pubmed
pubmed-article:9623096pubmed:monthMarlld:pubmed
pubmed-article:9623096pubmed:issn0028-2162lld:pubmed
pubmed-article:9623096pubmed:authorpubmed-author:VechtC JCJlld:pubmed
pubmed-article:9623096pubmed:authorpubmed-author:MarkusseH MHMlld:pubmed
pubmed-article:9623096pubmed:authorpubmed-author:van den...lld:pubmed
pubmed-article:9623096pubmed:issnTypePrintlld:pubmed
pubmed-article:9623096pubmed:day7lld:pubmed
pubmed-article:9623096pubmed:volume142lld:pubmed
pubmed-article:9623096pubmed:ownerNLMlld:pubmed
pubmed-article:9623096pubmed:authorsCompleteYlld:pubmed
pubmed-article:9623096pubmed:pagination508-12lld:pubmed
pubmed-article:9623096pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9623096pubmed:meshHeadingpubmed-meshheading:9623096-...lld:pubmed
pubmed-article:9623096pubmed:meshHeadingpubmed-meshheading:9623096-...lld:pubmed
pubmed-article:9623096pubmed:meshHeadingpubmed-meshheading:9623096-...lld:pubmed
pubmed-article:9623096pubmed:meshHeadingpubmed-meshheading:9623096-...lld:pubmed
pubmed-article:9623096pubmed:meshHeadingpubmed-meshheading:9623096-...lld:pubmed
pubmed-article:9623096pubmed:meshHeadingpubmed-meshheading:9623096-...lld:pubmed
pubmed-article:9623096pubmed:year1998lld:pubmed
pubmed-article:9623096pubmed:articleTitle[Immunology in medical practice. XIV. Central nervous system complications in systemic autoimmune diseases].lld:pubmed
pubmed-article:9623096pubmed:affiliationZuiderziekenhuis, afd. Reumatologie, Rotterdam.lld:pubmed
pubmed-article:9623096pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9623096pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:9623096pubmed:publicationTypeReviewlld:pubmed